AstrazenecaAZN
13F holders, Q2 2024 (June 30)4holders
1new positions
0sold out
$162.98avg. 13F price*
At the end of Q2 2024, 4 institutions reported holding Astrazeneca PLC (AZN) in their 13F filings, unchanged from Q1 2024. 1 opened new positions and 0 sold out. The largest holders were Boston Common Asset Management, LLC ($45.1M), Kennedy Capital Management LLC ($10.0M) and FNY Investment Advisers, LLC ($2.5M).
- Company
- Astrazeneca PLC
- CUSIP
- G0593M107
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $2.5M |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 26,892 shares bought and 10,893 shares sold, net +15,999 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| Boston Common Asset Management, LLC | 1.16% | Reduce -3.6% | 288,790 | $45.1M |
| Kennedy Capital Management LLC | 0.21% | Add +71.1% | 64,246 | $10.0M |
| FNY Investment Advisers, LLC | 1.68% | New | 200 | $2.5M |
| Raffa Wealth Management, LLC | 0.01% | No change | 464 | $36K |
"% of holder's portfolio" is AZN's weight in each manager's 13F, not the share of Astrazeneca PLC the manager owns.